Neurosurgical Team Acceptability of Brain-Computer Interfaces: A Two-Stage International Cross-Sectional Survey.

"Conflict of interest statement: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. S.W., J.F., J.H., H.L.H., W.M., D.S., and H.J.M., are supported by the 10.13039/100004440Wellcome (203145Z/16/Z) 10.13039/501100000266EPSRC (NS/A000050/1) 10.13039/501100020194Centre for Interventional and Surgical Sciences, 10.13039/501100000765University College London. H.J.M. is also funded by the 10.13039/100006662NIHR Biomedical Research Centre at 10.13039/501100000765University College London. A.T.S. is a Wellcome Trust Investigator (110174/Z/15/Z) and supported by the 10.13039/100010438Francis Crick Institute, which receives its core funding from 10.13039/501100000289Cancer Research UK (FC001153), the United Kingdom Medical Research Council (FC001153), and the 10.13039/100010269Wellcome Trust (FC001153). A.T.S. has cofounded and holds shares in Paradromics Inc., a company developing scalable electrophysiology. Neither A.T.S. nor Paradromics played any role in the design of this study."

"Conflict of interest statement: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. S.W., J.F., J.H., H.L.H., W.M., D.S., and H.J.M., are supported by the 10.13039/100004440Wellcome (203145Z/16/Z) 10.13039/501100000266EPSRC (NS/A000050/1) 10.13039/501100020194Centre for Interventional and Surgical Sciences, 10.13039/501100000765University College London. H.J.M. is also funded by the 10.13039/100006662NIHR Biomedical Research Centre at 10.13039/501100000765University College London. A.T.S. is a Wellcome Trust Investigator (110174/Z/15/Z) and supported by the 10.13039/100010438Francis Crick Institute, which receives its core funding from 10.13039/501100000289Cancer Research UK (FC001153), the United Kingdom Medical Research Council (FC001153), and the 10.13039/100010269Wellcome Trust (FC001153). A.T.S. has cofounded and holds shares in Paradromics Inc., a company developing scalable electrophysiology. Neither A.T.S. nor Paradromics played any role in the design of this study."